Assessment of day 2 glycaemia may provide a truer indicator of the quality of diabetes care and associated benefits,11 12 although we acknowledge that the glucose threshold for adverse outcomes does not necessarily determine the threshold for insulin intervention in a hospital setting. This evidence concerns the gene INS and diabetes mellitus.